Zekai Tahir Burak Maternity Teaching Hospital, Neonatology Unit
Ankara, 06600, Turkey (Türkiye)
NCT Number: NCT01362504
The aim of this study was to clarify the prognostic value of serum pro-Adrenomedullin level in neonatal sepsis. Eighty term and preterm neonates with sepsis were enrolled in this study. Eighty healthy matched neonates served as a control group.
Looking for future studies?
Notify Me24 week–42 week
All sexes
Observational
Ankara, 06600, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Zekai Tahir Burak Women's Health Research and Education Hospital
Other
Zekai Tahir Burak Maternity Teaching Hospital Neonatal Intensive Care Unit
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07375108
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Pavia, Italy
View Trial DetailsNCT03884894
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Pavia, PV, Italy
View Trial DetailsNCT01027429
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Karachi, Sindh, Pakistan
View Trial DetailsNCT01333982
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Bāndarban, Bangladesh
View Trial Details